53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
Hyfe pilot study tests a digital therapeutic combining passive cough monitoring with behavioral suppression techniques delivered through the CoughPro app.
This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.
Independent ERS 2025 NeuroCOUGH trial uses the Hyfe Cough Tracker to test feasibility of studying azithromycin's effect on cough and oesophageal motility.
Independent ERS 2025 trial uses the Hyfe Cough Tracker to show azithromycin reduces objective cough frequency by week one in chronic respiratory disease.
25.04.2022
Long coronavirus disease (COVID) refers to an array of variable and fluctuating symptomsexperienced after acute illness, with signs and symptoms that persist for 8–12 weeks andare not otherwise explicable. Cough is the most common symptom of acute COVID-19, butcough may persist in some individuals for weeks or months after recovery from acute phase.Long-COVID cough patients may get stigmatised because of the public fear of contagionand reinfection.
However, clinical characteristics and longitudinal course of long-COVIDcough have not been reported in detail, and evidence-based treatment is also lacking. In thispaper, we describe a case of long-COVID severe refractory cough with features of laryngealhypersensitivity and dysfunction. We characterized cough using patient-reported outcomesand engaged in continuous cough frequency monitoring. Through the case study, we discusspotential mechanisms, managements, and clinical implications of long-COVID refractorycough problems.
